NASDAQ:OXBR Oxbridge Re (OXBR) Stock Forecast, Price & News $1.26 +0.03 (+2.44%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$1.20▼$1.2950-Day Range$1.14▼$2.0452-Week Range$1.07▼$5.74Volume76,471 shsAverage Volume15,287 shsMarket Capitalization$7.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Oxbridge Re (NASDAQ:OXBR) StockOxbridge Re Holdings Ltd. engages in the provision of property and casualty reinsurance in the Gulf Coast region of the United States. Through its subsidiaries, it fully collateralizes policies to cover property losses from specified catastrophes. The company was founded by Sanjay Madhu on April 4, 2013 and is headquartered in George Town, Cayman Islands.Read More Receive OXBR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxbridge Re and its competitors with MarketBeat's FREE daily newsletter. Email Address OXBR Stock News HeadlinesMay 30, 2023 | finance.yahoo.comJET.AI PARTNERS WITH VEGAS GOLDEN KNIGHTS AND CIRRUS AVIATION TO PROVIDE FANS WITH BY-THE-SEAT PRIVATE JET EXPERIENCE TO AWAY GAMES-UPDATEDMay 28, 2023 | americanbankingnews.comOxbridge Re (NASDAQ:OXBR) Coverage Initiated by Analysts at StockNews.comJune 1, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 23, 2023 | theguardian.comSpare a thought for Britain’s new persecuted minority: the privately educatedMay 21, 2023 | americanbankingnews.comOxbridge Re (NASDAQ:OXBR) Coverage Initiated at StockNews.comMay 18, 2023 | thetimes.co.ukThe new Oxbridge trick — go private then switch to stateMay 18, 2023 | finance.yahoo.comOxbridge Re Holdings to Present at the LD Micro Invitational XIIIMay 17, 2023 | msn.comOxbridge softball races into region final with thrilling walk-offJune 1, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 13, 2023 | seekingalpha.comOxbridge Re GAAP EPS of $0.02, revenue of $0.55MMay 13, 2023 | finance.yahoo.comOxbridge Re Holdings Limited (NASDAQ:OXBR) Q1 2023 Earnings Call TranscriptMay 13, 2023 | americanbankingnews.comOxbridge Re (NASDAQ:OXBR) Earns Hold Rating from Analysts at StockNews.comMay 12, 2023 | finance.yahoo.comOxbridge Re Holdings Limited Reports First Quarter 2023 ResultsMay 9, 2023 | finance.yahoo.comOxbridge Re Announces 2023 First Quarter Results on May 12, 2023May 6, 2023 | thetimes.co.ukLord Woolley: We need adult conversations about slavery reparationsApril 21, 2023 | marketwatch.com9 Potential Investor Benefits of Oxbridge Reas (NASDAQ: OXBR) Web3 Startup SurancePlusApril 20, 2023 | finance.yahoo.com9 Potential Investor Benefits of Oxbridge Re’s (NASDAQ: OXBR) Web3 Startup SurancePlusApril 19, 2023 | americanbankingnews.comOxbridge Re (NASDAQ:OXBR) Receives New Coverage from Analysts at StockNews.comApril 13, 2023 | ft.comIn defence of OxbridgeApril 10, 2023 | americanbankingnews.comOxbridge Re (NASDAQ:OXBR) Now Covered by StockNews.comApril 7, 2023 | msn.comWhy were top local track and field athletes missing from the 2023 Palm Beach County Championship?April 6, 2023 | msn.comInside Barron Trump's Insanely Lavish LifeApril 5, 2023 | finance.yahoo.comOxbridge Re Holdings Limited (NASDAQ:OXBR) Q4 2022 Earnings Call TranscriptApril 3, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Oxbridge Re (NASDAQ:OXBR)April 1, 2023 | thetimes.co.ukWe chose America after Oxbridge rejected us — now we’re stayingMarch 30, 2023 | finance.yahoo.comOxbridge Re Holdings Limited Reports Fiscal 2022 ResultsMarch 30, 2023 | theguardian.comYour starter for 10: is University Challenge biased towards Oxbridge?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OXBR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxbridge Re and its competitors with MarketBeat's FREE daily newsletter. Email Address OXBR Company Calendar Last Earnings3/30/2023Today5/31/2023Next Earnings (Estimated)8/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Fire, marine, & casualty insurance Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:OXBR CUSIPN/A CIK1584831 Webwww.oxbridgere.com Phone(345) 749-7570FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,790,000.00 Net MarginsN/A Pretax Margin-89.23% Return on Equity-8.28% Return on Assets-7.52% Debt Debt-to-Equity RatioN/A Current Ratio9.87 Quick Ratio9.87 Sales & Book Value Annual Sales$850,000.00 Price / Sales8.90 Cash FlowN/A Price / Cash FlowN/A Book Value$2.59 per share Price / Book0.50Miscellaneous Outstanding Shares5,870,000Free Float4,516,000Market Cap$7.56 million OptionableNot Optionable Beta1.34 Key ExecutivesSanjay MadhuChairman, President & Chief Executive OfficerWrendon TimothyCFO, Secretary & Executive DirectorKey CompetitorsUnico AmericanNASDAQ:UNAMKingstone CompaniesNASDAQ:KINSFG Financial GroupNASDAQ:FGFConiferNASDAQ:CNFRNorthern Lights AcquisitionNASDAQ:NLITView All CompetitorsInstitutional OwnershipDimensional Fund Advisors LPSold 13,384 shares on 5/12/2023Ownership: 0.705%View All Institutional Transactions OXBR Stock - Frequently Asked Questions How have OXBR shares performed in 2023? Oxbridge Re's stock was trading at $1.20 on January 1st, 2023. Since then, OXBR stock has increased by 7.4% and is now trading at $1.2887. View the best growth stocks for 2023 here. Are investors shorting Oxbridge Re? Oxbridge Re saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 20,900 shares, a decline of 19.3% from the April 30th total of 25,900 shares. Based on an average daily volume of 13,800 shares, the days-to-cover ratio is presently 1.5 days. Approximately 0.4% of the company's shares are sold short. View Oxbridge Re's Short Interest. When is Oxbridge Re's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023. View our OXBR earnings forecast. How were Oxbridge Re's earnings last quarter? Oxbridge Re Holdings Limited (NASDAQ:OXBR) posted its quarterly earnings results on Thursday, March, 30th. The insurance provider reported $0.12 earnings per share for the quarter. The insurance provider had revenue of $1.04 million for the quarter. What other stocks do shareholders of Oxbridge Re own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oxbridge Re investors own include Bionano Genomics (BNGO), Organigram (OGI), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and Evolve Transition Infrastructure (SNMP). What is Oxbridge Re's stock symbol? Oxbridge Re trades on the NASDAQ under the ticker symbol "OXBR." Who are Oxbridge Re's major shareholders? Oxbridge Re's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (0.70%). View institutional ownership trends. How do I buy shares of Oxbridge Re? Shares of OXBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Oxbridge Re's stock price today? One share of OXBR stock can currently be purchased for approximately $1.29. How much money does Oxbridge Re make? Oxbridge Re (NASDAQ:OXBR) has a market capitalization of $7.56 million and generates $850,000.00 in revenue each year. The insurance provider earns $-1,790,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. How can I contact Oxbridge Re? Oxbridge Re's mailing address is SUITE 201 42 EDWARD STREET PO BOX 469, GEORGE TOWN E9, KY1-9006. The official website for the company is www.oxbridgere.com. The insurance provider can be reached via phone at (345) 749-7570. This page (NASDAQ:OXBR) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxbridge Re Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.